BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30880133)

  • 21. Postpubertal cherubism with Noonan syndrome.
    Ahmed B; Amin M
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S39-40. PubMed ID: 24718001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism.
    Bar Droma E; Beck-Rosen G; Ilgiyaev A; Fruchtman Y; Abramovitch-Dahan C; Levaot N; Givol N
    J Oral Maxillofac Surg; 2020 Dec; 78(12):2226-2234. PubMed ID: 32649899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
    Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Craniofacial and Dental Features in Six Children With Cherubism.
    Stoor P; Suomalainen A; Kemola W; Arte S
    J Craniofac Surg; 2017 Oct; 28(7):1806-1811. PubMed ID: 28857986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
    Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
    Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Man with cherubism].
    Hart W; Schweitzer DH; Slootweg PJ; Grootenhuis LS
    Ned Tijdschr Geneeskd; 2000 Jan; 144(1):34-8. PubMed ID: 10665301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
    Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
    Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cherubism With Bilateral Mandible and Maxilla Involvement: A Case Report.
    Yu Z; Zhai M; Gan W; Zhang H; Zhou Y; Wen H
    Medicine (Baltimore); 2015 Dec; 94(49):e2120. PubMed ID: 26656340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and molecular genetic observations on families with cherubism over three generations].
    Petschler M; Stiller M; Hoffmeister B; Witkowski R; Opitz C; Bill JS; Peters H
    Mund Kiefer Gesichtschir; 2003 Mar; 7(2):83-7. PubMed ID: 12664252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orbital involvement in cherubism.
    Carroll AL; Sullivan TJ
    Clin Exp Ophthalmol; 2001 Feb; 29(1):38-40. PubMed ID: 11272784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gene for cherubism maps to chromosome 4p16.
    Tiziani V; Reichenberger E; Buzzo CL; Niazi S; Fukai N; Stiller M; Peters H; Salzano FM; Raposo do Amaral CM; Olsen BR
    Am J Hum Genet; 1999 Jul; 65(1):158-66. PubMed ID: 10364528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
    Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
    Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Alendronic Acid in the Management of Severe Cherubism: A Case Report and Literature Review.
    Bradley D; Patel V; Honeyman C; McGurk M
    J Oral Maxillofac Surg; 2021 Mar; 79(3):598-607. PubMed ID: 33159843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and radiological features of nonfamilial cherubism: A case report.
    Wagel J; Luczak K; Hendrich B; Guziński M; Sąsiadek M
    Pol J Radiol; 2012 Jul; 77(3):53-7. PubMed ID: 23049582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
    Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
    Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of cherubism with eventual bilateral progression: a literature review and case report.
    Holley TJ; Giannini PJ; Narayana N; Desa VP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Mar; 127(3):e77-e83. PubMed ID: 30287203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism.
    Kawamura H; Watanabe S; I T; Asahina I; Moriuchi H; Dateki S
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):963-966. PubMed ID: 32649295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.